SAB Biotherapeutics (SABS) Treasury Shares (2022 - 2026)

SAB Biotherapeutics (SABS) has 5 years of Treasury Shares data on file, last reported at $5.5 million in Q1 2026.

• Quarterly Treasury Shares changed 0.0% year-over-year to $5.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.5 million (changed 0.0% YoY) and the FY2025 annual result came in at $5.5 million, changed 0.0% from the prior year.
• Treasury Shares steadied at $5.5 million in Q1 2026, from $5.5 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $668875.0 in Q1 2023 to a low of -$54665.0 in Q4 2023.
• A 5-year average of $193040.5 and a median of $54665.0 in 2025 frame the typical range for Treasury Shares.
• The widest YoY moves for Treasury Shares: up 0.0% in 2023, down 0.0% in 2023.
• Tracing SABS's Treasury Shares over 5 years: stood at $5.5 million in 2022, then changed by 0.0% to $5.5 million in 2023, then changed by 0.0% to $5.5 million in 2024, then changed by 0.0% to $5.5 million in 2025, then changed by 0.0% to $5.5 million in 2026.
• The last three Treasury Shares figures came in at $5.5 million (Q1 2026), $5.5 million (Q4 2025), and $5.5 million (Q3 2025), per Business Quant data.